Efficacy and safety of single-agent pertuzumab (rhuMAb 2C4), a human epidermal growth factor receptor dimerization inhibitor, in castration-resistant prostate cancer after progression from taxane-based therapy (Q44029404)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and safety of single-agent pertuzumab (rhuMAb 2C4), a human epidermal growth factor receptor dimerization inhibitor, in castration-resistant prostate cancer after progression from taxane-based therapy |
scientific article |
Statements
1 reference
Efficacy and safety of single-agent pertuzumab (rhuMAb 2C4), a human epidermal growth factor receptor dimerization inhibitor, in castration-resistant prostate cancer after progression from taxane-based therapy (English)
1 reference
1 reference
David B Agus
1 reference
Christopher J Sweeney
1 reference
David S Mendelson
1 reference
Douglas G McNeel
1 reference
Frederick R Ahmann
1 reference
Jin Wang
1 reference
Mika K Derynck
1 reference
Kimmie Ng
1 reference
Benjamin Lyons
1 reference
David E Allison
1 reference
Michael W Kattan
1 reference
Howard I Scher
1 reference
1 February 2007
1 reference
1 reference
Identifiers
1 reference